openPR Logo
Press release

Biosimulation Market Expanding at 15.9% CAGR to 2023 – Study on Rear Excessive Growth Estimated by Key Top Players Like Certara (US), Simulations Plus (US), Dassault Systèmes (France), Evidera (US), INOSIM Software (Germany) and Nuventra Pharma (US)

04-11-2019 03:48 PM CET | Health & Medicine

Press release from: ReportsnReports

Biosimulation Market

Biosimulation Market

Click Now for Download Free Sample of Biosimulation Market Report with 149 Market Data Tables with 57 Figures Across 318 Pages and In-depth TOC at http://www.rnrmarketresearch.com/contacts/request-sample?rname=398116 .

Biosimulation market is projected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%. Report also helps stakeholders understand pulse of market & provide them with information regarding key market drivers & opportunities.

Biosimulation market report will help stakeholders to understand competitive landscape better & gain insights to position their businesses & help companies make suitable go-to-market strategies. Report provides an overview of biosimulation market. It aims at estimating market size & future growth potential of this market across different segments like product & service, applications, delivery model, end user, & region.

Study estimates the biosimulation market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the biosimulation market

Target Audience for Biosimulation Market Report:
• Biosimulation product manufacturers, vendors, and distributors
• Market research and consulting companies
• Regulatory authorities
• Associations related to pharmaceutical and biotechnology research
• Biotechnology and pharmaceutical companies
• Academic and government research institutes
• Contract research organizations (CROs)

Click Now for Place the Order Now on Biosimulation Market Study Report Now at http://www.rnrmarketresearch.com/contacts/purchase?rname=398116 .

The biosimulation market estimation process, both top-down and bottom-up approaches were used to estimate and validate market size of biosimulation market as well as to estimate market size of various other dependent submarkets. All possible parameters that affect market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Some of top players in biosimulation market operating are Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).

Inquire for Discount On “Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022” research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=398116 .

North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in European region.

Key Benefits of Buying the Report:
The biosimulation market is segmented into software and services. The biosimulation services segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis, and consulting services.

RnRMarketResearch is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@rnrmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market Expanding at 15.9% CAGR to 2023 – Study on Rear Excessive Growth Estimated by Key Top Players Like Certara (US), Simulations Plus (US), Dassault Systèmes (France), Evidera (US), INOSIM Software (Germany) and Nuventra Pharma (US) here

News-ID: 1699830 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Biosimulation

Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Biosimulation Market Through 2025? The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Biosimulation Market Size and Projected Growth Rate? The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market? The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry. Global Biosimulation Market: Driven factors and Restrictions factors The research
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766 This latest report researches the industry structure, sales, revenue,